Vertaling van "have a calming – some " (Nederlands → Frans) :

The basic idea was that the use of writing is a first way of creating a distance that is likely to have a calming – some will even call it therapeutic – effect in itself. Sharing one’s experience with others can turn out to be interesting, and more importantly, these “others” can provide adequate answers to the questions raised.
Le postulat de base étant que le passage par l’écriture constitue une première mise à distance susceptible d’avoir un effet apaisant – certains diront même thérapeutique – en soi, le fait de partager son vécu avec d’autres pouvant s’avérer intéressant et, surtout, ces « autres » pouvant apporter une réponse adéquate aux questions soulevées.

Average Wholesale Price litigation Claims have been brought against various pharmaceutical companies, including NPC and certain Sandoz entities, alleging that they fraudulently overstated the Average Wholesale Price and “best price”, which are, or have been, used by the US federal and state governments in the calculation of, respectively, Medicare reimbursements and Medicaid rebates. In some cases, motions to dismiss or (cross-) motions for summary judgment have been made and are currently pending.
Litige concernant le prix de gros moyen Des plaintes ont été déposées contre différentes sociétés pharmaceutiques, dont NPC et certaines entités de Sandoz, au motif que celles-ci auraient frauduleusement exagéré le prix de gros moyen (average wholesale price [AWP]) et le «meilleur prix» qui sont ou ont été utilisés par le gouvernement fédéral américain et des gouvernements d’Etat pour calculer les remboursements des médicaments dans le cadre du programme Medicare et les rabais dans celui de Medicaid.

Average Wholesale Price litigation Claims have been brought against various pharmaceutical companies, including NPC and certain Sandoz entities, alleging that they fraudulently overstated the Average Wholesale Price and “best price”, which are, or have been, used by the US federal and state governments in the calculation of, respectively, Medicare reimbursements and Medicaid rebates. In some cases, motions to dismiss or (cross-) motions for summary judgment in other cases have been made and are currently pending.
Litige concernant le prix de gros moyen Des plaintes ont été déposées contre différentes sociétés pharmaceutiques, dont NPC et certaines entités de Sandoz, au motif que celles-ci auraient frauduleusement exagéré le prix de gros moyen (average wholesale price [AWP]) et le «meilleur prix» qui sont ou ont été utilisés par le gouvernement fédéral américain et des gouvernements d’Etat pour calculer les remboursements des médicaments dans le cadre du programme Medicare et les rabais dans celui de Medicaid.

So far, various initiatives have already been taken and some of them have been assessed.
A l’heure actuelle, différentes initiatives existent déjà et ont fait l’objet pour certaines d’une évaluation.

The Publisher regrets that in Annexe D: Dose Coefficients for Workers (pages 353-515) of the above volume, which has just been published, errors have been introduced into some of the tables.
The Publisher regrets that in Annexe D: Dose Coefficients for Workers (pages 353 - 515) of the above volume, which has just been published, errors have been introduced into some of the tables.

Some strains have caused local epidemics.
Certaines souches ont causé des épidémies locales.

some contexts in which these beverages are consumed (sports activities, in combination with alcohol) have been associated with a cardiovascular risk whilst exerting physical effort as well as a risk of lessened perception of the effects of alcohol. However, objectively, the latter remain intact.
certaines situations d’emploi de la boisson (activité sportive, prise concomitante d’alcool) sont associées d’une part à un risque cardio-vasculaire à l’exercice et, d’autre part, à un risque de perception amoindrie des effets de l’alcool qui demeurent toutefois.

Galvus/Eucreas (USD 115 million, +416% lc), oral treatments for type 2 diabetes, have been expanding rapidly in many European, Latin American and Asia-Pacific markets, and outperforming a competitor medicine in the DPP-IV segment in some countries.
Galvus/Eucreas (USD 115 millions, +416% en m. l.), traitements par voie orale du diabète de type 2, ont progressé rapidement dans de nombreux marches en Europe, en Amérique latine et en Asie-Pacifique.

Some achievements and figures for Unit II in 2007 Rapid alerts relating to the quality of medicines The Rapid Alerts System or RAS network is an international network whose purpose is to circulate information as quickly as possible about batches of medicines that have been identified as nonconforming, which were produced in non-GMP conditions or which do not belong to the distribution circuit that complies with the GDP.
Some achievements and figures for Unit II in 2007 Rapid alerts relating to the quality of medicines The Rapid Alerts System or RAS network is an international network whose purpose is to circulate information as quickly as possible about batches of medicines that have been identified as nonconforming, which were produced in non-GMP conditions or which do not belong to the distribution circuit that complies with the GDP.

Galvus and Eucreas, a single-pill combination of Galvus with metformin that accounts for the majority of sales, have outperformed a competitor medicine in the DPP-4 segment in some countries. Galvus was approved in Japan in January 2010 with the brand name Equa.
Galvus et Eucreas, un comprimé unique associant Galvus avec la metformine qui enregistre la majorité des ventes, ont surperformé dans certains pays un médicament concurrent dans le segment DPP-IV. Galvus a été homologué en janvier 2010 au Japon sous la marque Equa.